Showing results (1221-1230 of 1,547) with videos related to

Sort By:
Pageof 155
Nature Communications|August 16, 2022
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastomaShannon Coy, Shu Wang, Sylwia A Stopka, et al.
Neuro-Oncology|July 29, 2024
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumorsAnthony P Y Liu, Bryan K Li, Alexandre Vasiljevic, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 24, 2026
A Worldwide Survey on Pathological Measurement of Residual Breast Cancer After Neoadjuvant Therapy: Different Interpretations of the ypTNM ClassificationKoen Kwakkenbos, Mieke R Van Bockstal, Abeer M Shaaban, et al.
AJNR. American Journal of Neuroradiology|December 8, 2025
Focused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical ApplicationsAli Nabavizadeh, Kazim Narsinh, Timothy J Kaufmann, et al.
JAMA Oncology|December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A ReviewCraig Horbinski, David A Solomon, Rimas V Lukas, et al.
Science Translational Medicine|September 6, 2023
Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomasPierpaolo Peruzzi, Christine Dominas, Geoffrey Fell, et al.
Neuro-Oncology|December 8, 2021
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-makingMary Jane Lim-Fat, Gilbert C Youssef, Mehdi Touat, et al.
Neuro-Oncology|December 1, 2021
Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trialE Antonio Chiocca, Arnold B Gelb, Clark C Chen, et al.
Neuro-Oncology|September 26, 2015
CNS Anticancer Drug Discovery and Development Conference White PaperVictor A Levin, Peter J Tonge, James M Gallo, et al.
Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.
Pageof 155